Tag: Alexion
EU Clears AstraZeneca’s Acquisition Of Alexion
The European Commission has cleared AstraZeneca’s (AZ) proposed acquisition of rare disease specialist Alexion, initially announced in December 2020.
Last year, AZ revealed its plans...
UK & EU Antitrust Regulators Concerned Over AstraZeneca’s $39B Alexion Buy
EU & UK antitrust watchdogs are set to decide by this weekend whether to approve AstraZeneca’s US$39 billion bid for biopharmaceutical company Alexion, a...
AstraZeneca Delays FTC Review For $39B Alexion Deal
AstraZeneca is resetting the clock to give the Federal Trade Commission more time to review its roughly US$39 billion bid for Alexion Pharmaceuticals, the...
AstraZeneca To Buy Alexion For $39 Billion
Leading COVID-19 vaccine developer AstraZeneca agreed on Saturday, December 12, to buy Boston pharmaceutical firm Alexion for US$39 billion, reported The Wall Street Journal.
The...
